Aclarion CEO to Present at 2024 Maxim Healthcare Virtual Summit

Aclarion, Inc., a healthcare technology company specializing in chronic low back pain diagnosis, has announced its participation in the upcoming 2024 Maxim Healthcare Virtual Summit. The company's CEO, Brent Ness, is scheduled to present on October 15, 2024, at 2:00 p.m. ET, in a fireside chat format.

This invitation to present at the Maxim Group LLC-hosted summit signifies Aclarion's growing prominence in the healthcare technology sector. The event, which features a range of biotechnology, diagnostic, medical device, and healthcare information technology companies, provides a platform for Aclarion to showcase its innovative approach to addressing chronic low back pain.

Aclarion's flagship product, Nociscan, represents a significant advancement in the diagnosis and treatment of chronic low back pain. As the first evidence-supported SaaS platform of its kind, Nociscan utilizes Magnetic Resonance Spectroscopy (MRS), proprietary signal processing techniques, and augmented intelligence algorithms to help physicians differentiate between painful and non-painful discs in the lumbar spine.

The technology behind Nociscan is particularly noteworthy. It processes MRS data from MRI machines through cloud-based proprietary algorithms, extracting and quantifying chemical biomarkers associated with disc pain. This non-invasive approach provides critical insights into the location of a patient's low back pain, potentially revolutionizing treatment strategies for a condition that affects millions worldwide.

Aclarion's participation in the Maxim Healthcare Virtual Summit comes at a time when the healthcare industry is increasingly focusing on innovative, technology-driven solutions. The company's approach aligns with the growing trend of leveraging artificial intelligence and data analytics in medical diagnostics and treatment planning.

For investors and industry observers, Aclarion's presentation at the summit offers an opportunity to gain insights into the company's technology, market position, and future prospects. As a Nasdaq-listed company (ACON, ACONW), Aclarion's developments are of particular interest to those following advancements in healthcare technology and medical devices.

The virtual format of the summit, featuring presentations and interactive discussions with CEOs and key management, allows for broad participation and engagement. This setup provides Aclarion with a valuable platform to communicate its vision and strategy to a diverse audience of healthcare professionals, investors, and industry analysts.

As chronic low back pain continues to be a significant health issue globally, Aclarion's technology could have far-reaching implications for patient care and healthcare costs. The company's participation in high-profile events like the Maxim Healthcare Virtual Summit underscores the potential impact of its technology on the future of pain management and diagnostic practices in spine health.